Sygnis SA (WSE:SYG)
1.180
+0.020 (1.72%)
At close: Aug 14, 2026
Sygnis Market Cap
Sygnis has a market cap or net worth of 38.5 million as of August 14, 2026. Its market cap has increased by 0.35% in one year.
Market Cap
38.50M
Enterprise Value
36.58M
Revenue
13.02M
Ranking
n/a
PE Ratio
39.89
Stock Price
1.18
ChartMarket Cap Chart
Since March 16, 2012, Sygnis's market cap has increased from 6.21M to 38.50M, an increase of 520.15%. That is a compound annual growth rate of 13.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 38.50M | -35.01% |
| Dec 30, 2025 | 59.24M | 501.78% |
| Dec 30, 2024 | 9.84M | -56.47% |
| Dec 29, 2023 | 22.62M | -56.95% |
| Dec 30, 2022 | 52.54M | 10.53% |
| Dec 30, 2021 | 47.53M | 177.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.74B |
| NEUCA | 3.56B |
| Synektik Spólka Akcyjna | 3.12B |
| Voxel | 1.33B |
| Milton Essex Spólka Akcyjna | 50.03M |
| BioMaxima | 41.89M |
| Nestmedic | 39.95M |
| Pharmena | 34.53M |